Stempeutics weighs Japan tie-up for stem cell therapy
This article was originally published in Scrip
Executive Summary
Japan continues to attract interest in the area of regenerative medicine. Indian firm Stempeutics Research now says it is eyeing collaboration opportunities for its stem-cell based drug, Stempeucel, initially targeted for the treatment of critical limb ischemia.